Sai Life Sciences Limited has intimated the stock exchanges about scheduled meetings with analysts and investors in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, specifically Regulation 30 read with Schedule III.
The meetings are scheduled to take place on August 13, 2026 and August 14, 2026 in Singapore as part of the Avendus Spark INDX-Asia Edition 2026 event. The meetings will include both one-on-one and group formats.
The company specifically notes that no new presentation will be made during these meetings and confirms that no unpublished price sensitive information will be discussed. The disclosure also includes a disclaimer that the schedule may undergo changes due to exigencies on the part of either the analysts/investors or the company.
The intimation was signed by Runa Karan, Company Secretary & Compliance Officer (Membership No.: A13721), on August 4, 2026, at 12:33:16 IST.
Financial Impact
No financial impact disclosed. The meeting is for investor relations purposes only with no material financial announcements planned.